C18* (p.Cys18Ter) variant of KRT16 (Keratin, type I cytoskeletal 16)

C18* (p.Cys18Ter) in KRT16 (Keratin, type I cytoskeletal 16) is a protein-truncating change. Clinical records from EBI and UniProt describe it as likely benign. The available variant effect predictions contribute to a CATVariant prioritization score of 0.28 / 1. The record also includes population frequency data and structural context.

C18* (p.Cys18Ter) variant details